Obiettivo dello screening è ridurre il tasso di soggetti con complicanze correlate alla presenza di epatite cronica B. Si è infatti osservato che la somministrazione di farmaci efficaci porta a riduzione dei tassi di cirrosi e di cancro del fegato
Altro materiale utile
US Preventive Services Task Force Recommendation Statement. Screening for Hepatitis B virus in Adolescents and Adults. https://jamanetwork.com/journals/jama/fullarticle/2774056
Hepatitis B basic information. US Department of Health and Human Services. Published August 21, 2020. Accessed November 18, 2020. https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-b-basics/index.html
Guidelines for viral hepatitis surveillance and case management. Centers for Disease Control and Prevention. Published January 2005. Accessed October 22, 2020. https://www.cdc.gov/hepatitis/statistics/surveillanceguidelines.htm
Abara WE, et al; High Value Care Task Force of the American College of Physicians and the Centers for Disease Control and Prevention. Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention.
Ann Intern Med. 2017; 167(11):794-804. https://pubmed.ncbi.nlm.nih.gov/29159414/
Schede di approfondimento
ENGLISH
ITALIANO
FRANÇAIS
ROMÂNĂ
中文
العربية
Nota. Questi documenti hanno solo valore informativo e non intendono sostituire quanto affermato dal medico curante. Inoltre, come ogni documento, richiedono un aggiornamento periodico.